Safety analysis of COVID-19 vaccines in liver transplant recipients: a two-center study

Hepatobiliary Surg Nutr. 2022 Feb;11(1):166-168. doi: 10.21037/hbsn-21-392.

¹ Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Institute for Precision Medicine, Tsinghua University, Beijing, China.
² Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Amy Medical University), Chongqing, China.

No abstract available